CRNX
#983
Crinetics Pharmaceuticals, Inc. - Common Stock
83.6 7 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.11%
Monthly Change
+141.96%
6 month change
+52.35%
Year Change
+103.58%
Previous Close
83.5 8
Open
83.6 7
Low
83.6 7
High
83.6 7
Volume
98
Financials
- Market Capitalization 8.82 B
- Employee 594
- Founded 2008
- CEO N/A
- Website www.crinetics.com
- Headquarter Delaware, United States
- FIGI BBG00BC59224
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.07
Price to sales ratio
200.52
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 967 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 110.40 USD | -7.50% | -4.18% | +27.97% | +86.80% | 9.08 B USD | ||
| 968 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 76.11 USD | -0.12% | -6.56% | +8.54% | +13.94% | 9.03 B USD | ||
| 987 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 314.56 USD | -3.21% | -0.17% | +16.12% | +482.63% | 8.77 B USD | ||
| 1003 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.01 USD | -3.69% | -1.36% | +12.27% | +41.09% | 8.42 B USD |
Frequently asked questions about Crinetics Pharmaceuticals, Inc. - Common Stock
What is the Crinetics Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) is 83.67. Over the past 24 hours, the stock has changed by +0.11%. Follow the CRNX chart for real-time price dynamics.
What is the stock ticker of Crinetics Pharmaceuticals, Inc. - Common Stock?
Crinetics Pharmaceuticals, Inc. - Common Stock trades under the ticker CRNX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Crinetics Pharmaceuticals, Inc. - Common Stock stock going up?
CRNX has changed by +0.11% over the last week, +141.96% over the last month, and +103.58% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Crinetics Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Crinetics Pharmaceuticals, Inc. - Common Stock reported net income of -127.84 M for the last quarter. The previous quarter showed -122.81 M, which means net income changed by -4.10%.
How many employees does Crinetics Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Crinetics Pharmaceuticals, Inc. - Common Stock has 594 employees. Workforce size can provide additional context about the company's scale and operations.
What is Crinetics Pharmaceuticals, Inc. - Common Stock EBITDA?
Crinetics Pharmaceuticals, Inc. - Common Stock EBITDA is -142.6 M, and its EBITDA margin is -1 328.47%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Crinetics Pharmaceuticals, Inc. - Common Stock stock?
You can buy Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Crinetics Pharmaceuticals, Inc. - Common Stock stock?
Investing in Crinetics Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRNX chart and related analysis on metatrader.com as part of your research.